Repare Therapeutics Inc. (RPTX) Misses Q4 EPS by 5c

Repare Therapeutics Inc. (NASDAQ: RPTX) reported Q4 EPS of ($0.75), $0.05 worse than the analyst estimate of ($0.70). Revenue for the quarter came in at $18.2 million versus the consensus estimate of $9.72 million.

For earnings history and earnings-related data on Repare Therapeutics Inc. (RPTX) click here.

You May Also Be Interested In

• Walmart (WMT) PT Lowered to $130 at UBS on Investment Narrative's Competing Dynamics
• The Buckle (BKE) Tops Q2 EPS by 7c, Beats on Revenue
• Ubiquiti (UI) Tops Q4 EPS by 25c, Beats on Revenue